Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-012683
Filing Date
2014-03-13
Accepted
2014-03-13 18:05:21
Documents
1
Period of Report
2014-03-11

Document Format Files

Seq Description Document Type Size
1 rrd405487.html 4  
1 rrd405487.xml 4 3141
  Complete submission text file 0001181431-14-012683.txt   4509
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DYNAVAX TECHNOLOGIES 2929 SEVENTH STREET, SUITE 100 BERKELEY CA 94710
Business Address
Janssen Robert (Reporting) CIK: 0001580849 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34207 | Film No.: 14692194